Nosocomial infections caused by Crimean-Congo haemorrhagic fever virus.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
May 2020
Historique:
received: 17 10 2019
accepted: 03 12 2019
pubmed: 11 12 2019
medline: 2 2 2021
entrez: 11 12 2019
Statut: ppublish

Résumé

Crimean-Congo haemorrhagic fever (CCHF) is an acute febrile illness, often accompanied by haemorrhagic manifestations, with a high case fatality rate (CFR). The causative agent is CCHF virus (CCHFV), and is transmitted to humans mainly through tick bites or exposure to blood or tissues of viraemic patients or livestock. Human-to-human transmission usually occurs in hospital settings, and healthcare workers (HCWs) are mainly affected. A review on nosocomial CCHFV infections was performed to elucidate the routes and circumstances of CCHFV transmission in hospital settings. From 1953 to 2016, 158 published cases of CCHFV nosocomial infection in 20 countries in Africa, Asia and Europe were found. Almost all cases were symptomatic (92.4%), with an overall CFR of 32.4%. The majority of cases occurred in hospital clinics (92.0%) and 10 cases (8.0%) occurred in laboratories. Most cases occurred among HCWs (86.1%), followed by visitors (12.7%) and hospitalized patients (1.3%). Nursing staff (44.9%) and doctors (32.3%) were the most affected HCWs, followed by laboratory staff (6.3%). The primary transmission route was percutaneous contact (34.3%). Cutaneous contact accounted for 22.2% of cases, followed by exposure to aerosols (proximity) (18.2%), indirect contact (17.2%) and exposure to patient environment (8.1%). CCHFV can cause nosocomial infections with a high CFR. During the care and treatment of patients with CCHF, standard contact precautions, barrier precautions and airborne preventive measures should be applied. In order to improve patient safety and reduce healthcare-associated CCHFV exposure, there is a need for guidelines and education for HCWs to ensure that CCHF is appropriately included in differential diagnoses; this will enable early diagnosis and implementation of infection prevention measures.

Identifiants

pubmed: 31821852
pii: S0195-6701(19)30496-7
doi: 10.1016/j.jhin.2019.12.001
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-52

Informations de copyright

Copyright © 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Auteurs

K Tsergouli (K)

Department of Microbiology, National Reference Centre for Arboviruses and Haemorrhagic Fever Viruses, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: ktsergouli@gmail.com.

T Karampatakis (T)

Department of Microbiology, National Reference Centre for Arboviruses and Haemorrhagic Fever Viruses, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

A-B Haidich (AB)

Department of Hygiene, Social-Preventative Medicine and Medical Statistics, School of Medicine, Aristotle University of Thessaloniki, Greece.

S Metallidis (S)

Department of Internal Medicine, Infectious Diseases Unit, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

A Papa (A)

Department of Microbiology, National Reference Centre for Arboviruses and Haemorrhagic Fever Viruses, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH